These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15560654)

  • 21. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.
    van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Is statin treatment for children safe and effective?].
    Marchetti F; Cannioto Z
    Recenti Prog Med; 2008 Dec; 99(12):599-601. PubMed ID: 19388217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Disorders of lipid metabolism--diagnosis and therapy in general practice. 5: Hypercholesterolemia--drug therapy].
    Richter WO
    Fortschr Med; 1996 May; 114(15):193-5. PubMed ID: 8767938
    [No Abstract]   [Full Text] [Related]  

  • 24. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 25. [Heterozygotic familial hypercholesterolemia: argument for early treatment].
    Rosenburg D
    Arch Pediatr; 2004 Nov; 11(11):1410-1. PubMed ID: 15595191
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hyperlipidemia in children and adolescents].
    Koletzko B
    MMW Fortschr Med; 2008 Nov; 150(47):34-7. PubMed ID: 19186486
    [No Abstract]   [Full Text] [Related]  

  • 27. [Indications and effectiveness of medical management of hyper- cholesterolemia].
    Tikkanen MJ; Pyörälä K
    Duodecim; 1987; 103(17):1024-31. PubMed ID: 3322790
    [No Abstract]   [Full Text] [Related]  

  • 28. Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia.
    van der Graaf A; Rodenburg J; Vissers MN; Hutten BA; Wiegman A; Trip MD; Stroes ES; Wijburg FA; Otvos JD; Kastelein JJ
    J Pediatr; 2008 Jun; 152(6):873-8. PubMed ID: 18492534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. For patients who inherit homozygous familial hypercholesterolemia, 2 new treatments available.
    Morrow T
    Manag Care; 2013 Mar; 22(3):47-8. PubMed ID: 23610808
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy.
    Hedman M; Miettinen TA; Gylling H; Ketomäki A; Antikainen M
    J Pediatr; 2006 Feb; 148(2):241-6. PubMed ID: 16492436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia.
    Clauss SB; Holmes KW; Hopkins P; Stein E; Cho M; Tate A; Johnson-Levonas AO; Kwiterovich PO
    Pediatrics; 2005 Sep; 116(3):682-8. PubMed ID: 16140708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice].
    Olsson AG; Nilsson PM
    Lakartidningen; 2009 Mar 18-24; 106(12):854-7. PubMed ID: 19452786
    [No Abstract]   [Full Text] [Related]  

  • 33. [The treatment of familial hypercholesterolemia].
    Viener A; Brook GJ
    Harefuah; 1987 Apr; 112(8):402-5. PubMed ID: 3315897
    [No Abstract]   [Full Text] [Related]  

  • 34. [Polyphepan (lignin) as an hypocholesteremic agent].
    Frolkis AV; Abramzon MA; Kislova GD; Levanova VP
    Klin Med (Mosk); 1987 Jul; 65(7):48-52. PubMed ID: 3312799
    [No Abstract]   [Full Text] [Related]  

  • 35. [Tuberous xanthomas as the first manifestation of homozygous familial hypercholesterolaemia].
    Hammami H; Benmously R; Marrak H; Debbiche A; Souissi A; Ayed MB; Fenniche S; Mokhtar I
    Ann Dermatol Venereol; 2008 Dec; 135(12):892-4. PubMed ID: 19084711
    [No Abstract]   [Full Text] [Related]  

  • 36. Lomitapide for use in patients with homozygous familial hypercholesterolemia: a narrative review.
    Neef D; Berthold HK; Gouni-Berthold I
    Expert Rev Clin Pharmacol; 2016; 9(5):655-63. PubMed ID: 26943823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A First-in-Class Drug, Lomitapide, Tailored to Patients with Homozygous Familial Hypercholesterolemia is Just about Meeting with Good News to Them.
    Yoshida H
    J Atheroscler Thromb; 2017 Apr; 24(4):390-392. PubMed ID: 28239069
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia.
    Miltiadous G; Saougos V; Cariolou M; Elisaf MS
    Ann Clin Lab Sci; 2006; 36(3):353-5. PubMed ID: 16951279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced hype.
    Harrison DG; Brown WV; Raggi P
    Am J Cardiol; 2008 Aug; 102(3):368-9. PubMed ID: 18638604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin.
    Rodenburg J; Vissers MN; Wiegman A; Miller ER; Ridker PM; Witztum JL; Kastelein JJ; Tsimikas S
    J Am Coll Cardiol; 2006 May; 47(9):1803-10. PubMed ID: 16682304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.